Evidence map›Paper›PMID 36584882›Full record

ReviewNeuropharmacology2023

Key differences in regulation of opioid receptors localized to presynaptic terminals compared to somas: Relevance for novel therapeutics.

Basile Coutens, Susan L Ingram

Abstract readReview
In one paragraph

Review in Neuropharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair.International journal of molecular sciences · 2026
    Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Opioid Receptors Modulate Inhibition within the Prefrontal Cortex through Dissociable Cellular and Molecular Mechanisms.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2025
    Article
  13. Endogenous opioids and the development of the mammalian respiratory control network.American journal of physiology. Lung cellular and molecular physiology · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. A Comprehensive 4-layeredCurrent pharmaceutical biotechnology · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Basile CoutensDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA.
Susan L IngramDepartment of Anesthesiology, University of Colorado Anschutz Medical Campus, Aurora, CO, 80045, USA. Electronic address: susan.ingram@cuanschutz.edu.

Funding

Defining the descending pain modulatory circuitR01NS120486 · NINDS · UNIVERSITY OF COLORADO DENVER · PI HEINRICHER, MARY MAGDALEN, INGRAM, SUSAN L · 2021 to 2025
$2.5M
Cannabinoid and opioid modulation of descending pain circuits in chronic painR01DA042565 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI HEINRICHER, MARY MAGDALEN, INGRAM, SUSAN L · 2017 to 2021
$2.0M
NIDA NIH HHS R01 DA042565NINDS NIH HHS R01 NS120486
6 · The paper itself

Abstract

Opioid receptors are G protein-coupled receptors (GPCRs) that regulate activity within peripheral, subcortical and cortical circuits involved in pain, reward, and aversion processing. Opioid receptors are expressed in both presynaptic terminals where they inhibit neurotransmitter release and postsynaptic locations where they act to hyperpolarize neurons and reduce activity. Agonist activation of postsynaptic receptors at the plasma membrane signal via ion channels or cytoplasmic second messengers. Agonist binding initiates regulatory processes that include phosphorylation by G protein receptor kinases (GRKs) and recruitment of beta-arrestins that desensitize and internalize the receptors. Opioid receptors also couple to effectors from endosomes activating intracellular enzymes and kinases. In contrast to postsynaptic opioid receptors, receptors localized to presynaptic terminals are resistant to desensitization such that there is no loss of signaling in the continuous presence of opioids over the same time scale. Thus, the balance of opioid signaling in circuits expressing pre- and postsynaptic opioid receptors is shifted toward inhibition of presynaptic neurotransmitter release during continuous opioid exposure. The functional implication of this shift is not often acknowledged in behavioral studies. This review covers what is currently understood about regulation of opioid/nociceptin receptors, with an emphasis on opioid receptor signaling in pain and reward circuits. Importantly, the review covers regulation of presynaptic receptors and the critical gaps in understanding this area, as well as the opportunities to further understand opioid signaling in brain circuits. This article is part of the Special Issue on "Opioid-induced changes in addiction and pain circuits".

Indexed as

Presynaptic TerminalsReceptors, OpioidAnalgesics, OpioidHumansNeuronsNeurotransmitter AgentsPainReceptors, Opioid, muAnalgesics, OpioidNeurotransmitter AgentsReceptors, OpioidReceptors, Opioid, muAddictionDesensitizationInternalizationOpioidsPainPresynaptic

Identifiers

PMID36584882
PMCPMC9898207

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.